[HTML][HTML] Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
K Krebs, L Milani - Human genomics, 2019 - Springer
The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good.
K Krebs, L Milani - Human Genomics, 2019 - search.ebscohost.com
The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
K Krebs, L Milani - Human genomics, 2019 - pubmed.ncbi.nlm.nih.gov
The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
[HTML][HTML] Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
K Krebs, L Milani - Human Genomics, 2019 - humgenomics.biomedcentral.com
The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good.
K Krebs, L Milani - Human Genomics, 2019 - europepmc.org
The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
K Krebs, L Milani - Human Genomics, 2019 - search.proquest.com
The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
[引用][C] Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
K Krebs, L Milani - Human Genomics, 2019 - cir.nii.ac.jp
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of
the good | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
the good | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[HTML][HTML] Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
K Krebs, L Milani - Human Genomics, 2019 - ncbi.nlm.nih.gov
The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
K Krebs, L Milani - Human Genomics, 2019 - go.gale.com
The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good.
K Krebs, L Milani - Human Genomics, 2019 - europepmc.org
The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …